Okogen Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $3.3M

  • Investors
  • 2

Okogen General Information

Description

Developer of an ophthalmic specialty platform designed to treat unmet needs in ophthalmic infectious diseases. The company's platform focuses on infectious ocular diseases where treatments are either not available or unsatisfactory and provides an opportunity to address adenoviral infections of the eye as well as other classes of viruses that are active in the ocular space, enabling patients to reduce suffering, improve quality of life and preserve vision.

Contact Information

Website
www.okogen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8400 Belleview Drive
  • Suite 125
  • Plano, TX 75024
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 8400 Belleview Drive
  • Suite 125
  • Plano, TX 75024
  • United States

Okogen Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Okogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 11-Dec-2024 $3.3M Completed Clinical Trials - Phase 2
2. Later Stage VC 09-Jan-2024 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 27-Feb-2018 $10M $10M Completed Pre-Clinical Trials
To view Okogen’s complete valuation and funding history, request access »

Okogen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
To view Okogen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Okogen Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Okogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021259787-A1 Treatment of viral conjunctivitis Pending 23-Apr-2020
EP-4138882-A1 Treatment of viral conjunctivitis Pending 23-Apr-2020
CA-3180714-A1 Treatment of viral conjunctivitis Pending 23-Apr-2020
JP-2023522953-A Treatment of viral conjunctivitis Pending 23-Apr-2020
US-20230218726-A1 Treatment of viral conjunctivitis Pending 23-Apr-2020 A61K38/465
To view Okogen’s complete patent history, request access »

Okogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Okogen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Biocatalyst Venture Capital Minority
Brandon Capital Venture Capital Minority
To view Okogen’s complete investors history, request access »

Ready to get started?

Request a free trial

Okogen FAQs

  • When was Okogen founded?

    Okogen was founded in 2015.

  • Where is Okogen headquartered?

    Okogen is headquartered in Plano, TX.

  • What is the size of Okogen?

    Okogen has 6 total employees.

  • What industry is Okogen in?

    Okogen’s primary industry is Drug Discovery.

  • Is Okogen a private or public company?

    Okogen is a Private company.

  • What is the current valuation of Okogen?

    The current valuation of Okogen is .

  • What is Okogen’s current revenue?

    The current revenue for Okogen is .

  • How much funding has Okogen raised over time?

    Okogen has raised $13.5M.

  • Who are Okogen’s investors?

    Brandon Biocatalyst and Brandon Capital have invested in Okogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »